• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 6-K/A filed by Alpine Summit Energy Partners Inc.

    10/31/25 8:22:03 AM ET
    $ALPS
    Get the next $ALPS alert in real time by email
    6-K/A 1 form6-ka.htm 6-K/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Amendment No. 1

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of October 2025

    Commission File Number 001-42915

     

    Alps Group Inc

     

    Unit E-18-01 & E-18-02, Level 18, Icon Tower (East)

    No. 1, Jalan 1/68F, Jalan Tun Razak

    50400 Kuala Lumpur

    Wilayah Persekutuan, Malaysia

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Amendment No. 1 to Form 6-K (the “Amendment”) of Alps Group Inc (“Alps”) amends the report on Form 6-K previously filed with the Securities and Exchange Commission on October 30, 2025 (the “Original Form 6-K”), and is being filed solely to (i) revise the market effective date of Alp’s Ordinary Shares to October 31, 2025; (ii) update the trading symbol of Alps warrants to “ALPWF”; and (iii) update the press release announcing the closing of the Business Combination with Globalink Investment Inc., a Delaware corporation (“Globalink”). Except as set forth above, no other changes were made.

     

    Except as expressly set forth above, this Amendment does not, and does not purport to, amend, update or restate the information in any other item of the Original Form 6-K or reflect any events that have occurred after the filing of the Original Form 6-K.

     

     

     

     

    Closing of the Business Combination

     

    On October 28, 2025, Alps Global Holding Pubco, a Cayman Islands exempted company (the “Company”), completed a business combination (the “Business Combination”) with Globalink Investment Inc., a Delaware corporation (“Globalink”). Upon the closing of the Business Combination, the Company changed its name to Alps Group Inc.

     

    As a result of the Business Combination, the Company’s ordinary shares are expected to begin trading on Nasdaq under the symbol ALPS, and the Company’s warrants are expected to sold on the OTCID Basic Market under the symbol ALPWF, effective October 31, 2025.

     

    The Business Combination was completed pursuant to the Merger Agreement dated as of January 30, 2024, as amended and restated on May 20, 2024, and further amended on March 6, 2025, April 18, 2025, and September 27, 2025, by and among the Company, Globalink and the other parties thereto.

     

    On October 31, 2025, the Company issued a press release announcing the Closing. A copy of the press release is attached hereto as Exhibit 99.1.

     

    The Company, Globalink and Alps Holdco are parties to subscription agreements (collectively, the “Subscription Agreements”) with certain investors (the “PIPE Investors”) pursuant to which the PIPE Investors purchased an aggregate of 310,788 Ordinary Shares of the Company for an aggregate subscription amount of US$3,107,875. The private placement was consummated substantially concurrently with the Closing. On October 10, 2025, the PIPE Investors, together with certain former shareholders of Globalink, also entered into the Amended and Restated Registration Rights Agreement with the Company pursuant to which the Company will, among other things, file a resale shelf registration statement on behalf of the stockholders no later than 60 days after the Closing. The Amended and Restated Registration Rights Agreement also provide certain demand registration rights and piggyback registration rights to the shareholders, subject to underwriter cutbacks and issuer blackout periods.

     

    The foregoing description of the Amended and Restated Registration Rights Agreement is qualified in its entirety by the terms of the Amended and Restated Registration Rights Agreement attached hereto and incorporated herein as Exhibit 10.1.

     

    Important Notice Regarding Forward-Looking Statements

     

    This Report on Form 6-K contains certain “forward-looking statements” within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Statements that are not historical facts, including statements about the Company’s perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the effect of the completed business combination transaction, including the benefits of the proposed transaction, anticipated future financial and operating performance and results, plans for growth, and the expected management and governance of the combined company. The words “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including assumptions about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those indicated or anticipated.

     

    The forward-looking statements are based on the current expectations of the management of the Company, and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statements. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements including: risks related to the Company’s businesses and strategies; the ability to recognize the anticipated benefits of the business combination; other risks and uncertainties included under the header “Risk Factors” in the registration statement on Form F-4, filed by the Company with the SEC; and in Globalink’s and the Company’s other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company and its subsidiaries undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

     

     

     

     

    Exhibit No.   Description
       
    10.1   Amended and Restated Registration Rights Agreement, dated October 10, 2025, by and among Alps Global Holding Pubco, GL Sponsor LLC, Alps Life Sciences Inc., and certain individuals (Incorporated by reference to Exhibit 10.1 to the Form 6-K filed with the Securities and Exchange Commission on October 30, 2025).
    99.1   Press Release dated October 31, 2025.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: October 31, 2025

     

      By: /s/ Tham Seng Kong
      Name: Tham Seng Kong
      Title: Chief Executive Officer and Director

     

     

     

    Get the next $ALPS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALPS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ALPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

    KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced a potential expansion of its exosome-related pipeline beyond its previously disclosed CELESOME(+) program. The announcement follows the publication of a preliminary retrospective clinical case series in SAGE Open Medical Case Reports describing nebulized human umbilical cord mesenchymal stem cell ("hUCMSC") derived exosome in patient with asthma and/or chronic obstructive pulmonar

    1/30/26 8:00:00 AM ET
    $ALPS

    Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer

    KUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (NASDAQ:ALPS) (the "Company" or "Alps Group"), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced the appointment of Cheing Lye-Ping (Penny) as Chief Financial Officer (CFO) of the Company, effective January 5, 2026. Ms. Cheing will be responsible for leading the development of the financial strategy to support the business, including investment strategies and long-term financial plans. She will also oversee financial budgeting, planning and analysis, audit, and tax compliance for Alps Group and subsidiaries, as well as ris

    1/8/26 8:00:00 AM ET
    $ALPS

    Alpine Announces Status of Sale Process

    Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - June 21, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") today announced that its Board of Directors unanimously voted to conclude its previously announced asset sale process, which was being conducted by Stephens Inc. ("Stephens").Beginning on March 8, 2023, Stephens broadly solicited expressions of interest in a sale of various strategic, highly productive assets recently developed and proven by the Company. After considering several bids, the Company's Board of Directors concluded that the bids were not reflective of the value of the underlying assets and it wa

    6/21/23 7:15:00 PM ET
    $ALPS

    $ALPS
    SEC Filings

    View All

    SEC Form 6-K filed by ALPS Group Inc

    6-K - Alps Group Inc (0002025774) (Filer)

    2/4/26 9:14:49 PM ET
    $ALPS

    SEC Form 6-K filed by ALPS Group Inc

    6-K - Alps Group Inc (0002025774) (Filer)

    1/30/26 4:00:28 PM ET
    $ALPS

    SEC Form 424B3 filed by ALPS Group Inc

    424B3 - Alps Group Inc (0002025774) (Filer)

    1/21/26 4:00:52 PM ET
    $ALPS

    $ALPS
    Leadership Updates

    Live Leadership Updates

    View All

    Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer

    KUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (NASDAQ:ALPS) (the "Company" or "Alps Group"), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced the appointment of Cheing Lye-Ping (Penny) as Chief Financial Officer (CFO) of the Company, effective January 5, 2026. Ms. Cheing will be responsible for leading the development of the financial strategy to support the business, including investment strategies and long-term financial plans. She will also oversee financial budgeting, planning and analysis, audit, and tax compliance for Alps Group and subsidiaries, as well as ris

    1/8/26 8:00:00 AM ET
    $ALPS

    $ALPS
    Financials

    Live finance-specific insights

    View All

    Alpine Summit Energy Partners Announces Full Year 2022 Financial and Operating Results

    Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - March 27, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") is pleased to announce its financial and operating results for the year ended December 31, 2022. Alpine Summit's audited consolidated financial statements and notes, as well as management's discussion and analysis (the "MD&A") and its Annual Report on Form 10-K for the year ended December 31, 2022 will be available under the Company's issuer profile at "www.sedar.com" and "www.sec.gov/edgar", as well as on the Company's website at "www.alpinesummitenergy.com".Craig Perry, Chief Executive Officer, remarked:

    3/27/23 7:00:00 AM ET
    $ALPS

    Alpine Summit Energy Partners Announces Strategic Review of Assets

    Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") today announced that the Board of Directors is commencing a strategic review of its assets. The Company seeks to facilitate a timely and orderly response to unsolicited inquiries by other upstream oil and gas companies who have expressed interest in acquiring various assets of the Company. The goal of the review is to maximize shareholder value and better position the Company for long-term stability and growth.Given the Company's decision to initiate this strategic review, alongside the historic volatil

    2/23/23 8:00:00 AM ET
    $ALPS

    Alpine Summit Energy Partners Announces February 2023 Dividend

    Nashville, Tennessee and Vancouver, British Columbia--(Newsfile Corp. - February 1, 2023) - Alpine Summit Energy Partners, Inc. (TSXV:ALPS) (NASDAQ:ALPS) ("Alpine Summit" or the "Company") is pleased to announce that, in accordance with its current monthly dividend policy, the Board of Directors of the Company has declared a dividend of US$0.0315 per subordinate voting share for the month of February 2023. Simultaneously with declaring the dividend on the subordinate voting shares, the directors also declared a dividend on the Company's multiple voting shares equal to US$3.15 per share and a dividend on the Company's proportionate voting shares equal to US$0.0315 per share.The dividend is pa

    2/1/23 8:00:00 AM ET
    $ALPS